This inventor holds 1 USPTO granted patent. Top assignee: Riken Corporation. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Hirochika Kawakami: Innovator in Mitochondrial Research
Introduction
Hirochika Kawakami is a prominent inventor based in Wako, Japan. He is known for his significant contributions to the field of mitochondrial research. His work focuses on developing novel compounds that can inhibit mitochondrial permeability transition pore (mPTP) opening, which has implications for various diseases.
Latest Patents
Kawakami holds a patent for a compound that acts as a mitochondrial permeability transition pore (mPTP)-opening inhibitor. This invention aims to provide a novel compound exhibiting high mPTP-opening inhibitory activity and useful therapeutic effects. The patent details a compound represented by a specific formula, which includes various stereoisomers, prodrugs, and pharmaceutically acceptable salts or solvates.
Career Highlights
Kawakami is associated with Riken Corporation, a leading research institution in Japan. His work has garnered attention for its potential therapeutic applications in treating diseases related to mitochondrial dysfunction. He has made strides in understanding the mechanisms of mPTP and its role in cellular health.
Collaborations
Kawakami has collaborated with notable colleagues, including Tadafumi Kato and Mie Sakashita. These collaborations have furthered research in mitochondrial biology and the development of innovative therapeutic strategies.
Conclusion
Hirochika Kawakami's contributions to mitochondrial research and his innovative patent highlight his role as a key inventor in the field. His work continues to pave the way for advancements in therapeutic interventions for various diseases.